Literature DB >> 12880686

Feedback regulation by IgG antibodies.

Birgitta Heyman1.   

Abstract

Antibodies of all classes and subclasses except IgD have been shown to have the capacity to feedback regulate the production of themselves. This phenomenon has been known for over a century and was originally described by the first Nobel laureate in physiology, Emil von Behring. When an animal is immunized with antibodies together with an antigen they recognize, the antibody response to this very antigen is often dramatically modulated. Sometimes feedback regulation results in complete suppression and sometimes in several 100-fold enhancement of the specific response. An immune complex contains the antigen, the specific antibodies bound to it and, when the antibodies can activate complement, complement factors, and can, therefore, bind to antigen-specific receptors on B cells (BCR), various Fc-receptors (FcRs) as well as to complement receptors. This gives the immune complex many possibilities to regulate the immune response via e.g. receptor cocrosslinking, leading to changes in signal transduction, or by increased antigen uptake and processing by antigen-presenting cells. This review will focus on the role of IgG as a feedback regulator. Three different pathways will be discussed: (i) the ability of IgG to induce complete suppression of erythrocyte responses, which takes place equally efficiently in the absence as in the presence of FcgammaRs, (ii) the ability of IgG to enhance responses to soluble protein antigens, a phenomenon severely impaired in FcRgamma-chain-deficient mice (with non-functional FcgammaRI and FcgammaRIII), and (iii) the ability of IgG to, via FcgammaRIIB, downregulate the response to IgG-complexed soluble antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880686     DOI: 10.1016/s0165-2478(03)00078-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  25 in total

Review 1.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies.

Authors:  Constanze Hess; André Winkler; Alexandra K Lorenz; Vivien Holecska; Véronique Blanchard; Susanne Eiglmeier; Anna-Lena Schoen; Josephine Bitterling; Alexander D Stoehr; Dominique Petzold; Tim Schommartz; Maria M M Mertes; Carolin T Schoen; Ben Tiburzy; Anne Herrmann; Jörg Köhl; Rudolf A Manz; Michael P Madaio; Markus Berger; Hedda Wardemann; Marc Ehlers
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

Review 3.  Future prospects in biologic therapy for systemic lupus erythematosus.

Authors:  William Stohl
Journal:  Nat Rev Rheumatol       Date:  2013-09-10       Impact factor: 20.543

4.  CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme.

Authors:  Xue Qiang Zhao; Ming Wei Zhang; Fei Wang; Yu Xia Zhao; Jing Jing Li; Xu Ping Wang; Pei Li Bu; Jian Min Yang; Xiao Ling Liu; Ming Xiang Zhang; Fei Gao; Cheng Zhang; Yun Zhang
Journal:  J Lipid Res       Date:  2011-03-01       Impact factor: 5.922

5.  Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.

Authors:  Richard J Stopforth; Robert J Oldham; Alison L Tutt; Patrick Duriez; H T Claude Chan; Brock F Binkowski; Chad Zimprich; Dun Li; Philip G Hargreaves; Mei Cong; Venkat Reddy; Maria J Leandro; Geraldine Cambridge; Anja Lux; Falk Nimmerjahn; Mark S Cragg
Journal:  J Immunol       Date:  2018-01-19       Impact factor: 5.422

6.  FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival.

Authors:  María C Amezcua Vesely; Marc Schwartz; Daniela A Bermejo; Carolina L Montes; Kelly M Cautivo; Alexis M Kalergis; David J Rawlings; Eva V Acosta-Rodríguez; Adriana Gruppi
Journal:  J Immunol       Date:  2012-04-18       Impact factor: 5.422

7.  Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor Fc gamma RIIB expression on B cells.

Authors:  Jefferson R Victor; Bruno P Muniz; Ana E Fusaro; Cyro A de Brito; Eliana F Taniguchi; Alberto J S Duarte; Maria N Sato
Journal:  BMC Immunol       Date:  2010-03-11       Impact factor: 3.615

8.  Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

9.  Mannan-binding lectin deficiency modulates the humoral immune response dependent on the genetic environment.

Authors:  Marieta Ruseva; Martin Kolev; Frederik Dagnaes-Hansen; Soren B Hansen; Kazue Takahashi; Alan Ezekowitz; Steffen Thiel; Jens C Jensenius; Mihaela Gadjeva
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

10.  Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19.

Authors:  Dániel Szili; Marcell Cserhalmi; Zsuzsanna Bankó; György Nagy; David E Szymkowski; Gabriella Sármay
Journal:  MAbs       Date:  2014-04-23       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.